Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00353275 · ClinicalTrials.gov registry record · NA
Hyperglycemia in Surgical Infections
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00353275 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 5 participants.
The verdict
NCT00353275, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.
Interventions
- DRUG Strict Glycemic control
- DRUG Conventional Glycemic Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00353275
The ClinicalTrials.gov registry entry for NCT00353275 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Strict Glycemic control is the first listed.
NCT00353275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00353275 about?
NCT00353275 is a clinical study titled "Hyperglycemia in Surgical Infections". The primary purpose of this study is to evaluate two glycemic control regimens on clinical outcome in patients with necrotizing soft tissue infections. Secondary aim is to evaluate the inflammatory and immune responses to the glycemic control regimens.
What is the current status of trial NCT00353275?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2009-08. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00353275?
The interventions under investigation include: Strict Glycemic control (DRUG), Conventional Glycemic Control (DRUG).
Who is sponsoring clinical trial NCT00353275?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.